The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PHASE II evaluation of dalantercept for persistent or recurrent epithelial ovarian and related cancers: An NRG oncology study.
 
Robert Allen Burger
Consulting or Advisory Role - Boehringer Ingelheim; Genentech/Roche; Janssen Research & Development; Nucana; Oxigene
 
Wei Deng
No Relationships to Disclose
 
Vicky Makker
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Heidi J. Gray
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Celgene; Seagen
 
Steven E. Waggoner
No Relationships to Disclose
 
Douglas A. Levine
No Relationships to Disclose